Chemical permeation enhancers for transbuccal drug delivery

Expert Opinion on Drug Delivery

Volumn 7, Issue 1, 2010, Pages 97-112

  Hassan, Nisreen ^a   Ahad, Abdul ^a   Ali, Mushir ^a   Ali, Javed ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Buccal drug delivery; Chemical permeation enhancer; Permeation mechanism; Sorption promoter

Indexed keywords

BENZALKONIUM CHLORIDE; CETYLPYRIDINIUM SALT; CHITOSAN; CYCLODEXTRIN; DODECYL SULFATE SODIUM; EDETATE SODIUM; GLYCOCHOLATE SODIUM; GLYCODEOXYCHOLIC ACID; LAURIC ACID; LAUROCAPRAM; MACROGOL; MENTHOL; PENETRATION ENHANCING AGENT; PHOSPHATIDYLCHOLINE; POLIDOCANOL; POLYSORBATE; SALICYLATE SODIUM; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID;

DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG PENETRATION; DRUG STRUCTURE; DRUG TRANSPORT; MEMBRANE PERMEABILITY; NONHUMAN; REVIEW;

CHEEK; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH MUCOSA; PERMEABILITY;

EID: 73649137203     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240903338758     Document Type: Review

References (122)

1. Hoogstraate AJ, Wertz PHW. Drug delivery via the buccal mucosa. Pharm Sci Tech Today 1998;1:309-316
2. Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992;81:1-10
3. Rossi S, Sandri G, Caramella CM. Buccal drug delivery: a challenge already won? Drug Discov Today 2005;2:59-65
4. Scholz OA, Wolff A, Schumacher A, et al. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. Drug Discov Today 2008;13:247-253
5. Gandhi RB, Robinson JR. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev 1994;13:43-74
6. Galey WR, Lonsdale HK, Nacht S. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. J Invest Dermatol 1976;67:713-717
7. Senel S, HIncal AA. Drug permeation enhancement via buccal route: possibilities and limitations. J Control Release 2001;72:133-144
8. Giannola LI, Caro VD, Giandalia G, et al. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features. Eur J Pharm Biopharm 2007;65:238-246
9. Rathbone MJ, Tucker IG. Mechanisms, barriers and pathways of oral mucosal drug permeation. Adv Drug Deliv Rev 1993;12:41-60
10. Whitehead K, Mitragotri S. Mechanistic analysis of chemical permeation enhancers for oral drug delivery. Pharm Res 2008;25(6):1412-1419
11. Hoogstraate AJ, Verhoef JC, Pijpers A, et al. In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm Res 1996;13:1233-1237 (Pubitemid 26279331)
12. Merkle HP, Wolany G. Buccal delivery for peptide drugs. J Control Release 1992;21:155-164
13. Anders R, Merckle HP, Schurr W, Ziegler R. Buccal absorption of protirelin: an effective way to stimulate thyrotropin and prolactin. J Pharm Sci 1983;72:1481-1483
14. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut 1998;1(1):15-30
15. Martin L, Wilson CG, Koosha F, Uchegbu IF. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm 2003;55:35-45
16. Singh B, Ahuja N. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm 2002;28:431-442
17. Liu C, Xu HN, Li XL. In vitro permeation of tetramethylpyrazine across porcine buccal mucosa. Acta Pharmacol Sin 2002;23:792-796
18. Siegel IA, Gordon HP. Penetration of oral mucosa by organic compounds. J Dent Res 1979;58:109-110
19. Siegel IA, Izutsu KT, Watson E. Mechanisms of non electrolyte penetration across dog and rabbit oral mucosa in vitro. Arch Oral Biol 1981;26:357-361
20. Siegel IA. Permeability of the rat oral mucosa to organic solutes measured in vivo. Arch Oral Biol 1984;29:13-16
21. Sadoogh-Abasian F, Evered DF. Absorption of vitamin C from the human buccal cavity. Br J Nutr 1979;42:15-20
22. Manning AS, Evered DF. The absorption of sugars from the human oral cavity. Clin Sci Mol Med 1976;51:127-132
23. McMullan JM, Manning AS, Evered DF. Effect of calcium ions on the uptake of sugars through the human buccal mucosa. Biochem Soc Trans 1977;5:129-130
24. Evered DF, Offer RM. Aspirin inhibition of glucose absorption from the human mouth. Biochem Soc Trans 1981;9:133-134
25. Evered DF, Sadoogh-Abasian F, Patel PD. Absorption of nicotinic acid and nicotinamide across human buccal mucosa. Life Sci 1980;27:1649-1651 (Pubitemid 11220221)
26. Evered DF, Mallett C. Thiamine absorption across human buccal mucosa. Life Sci 1983;32:1355-1358
27. Hunjan MK, Evered DF. Absorption of glutathione from the gastrointestinal tract. Biochim Biophys Acta 1985;815:184-185
28. Evered DF, Vadgama JV. Absorption of aminoacids from the human buccal cavity. Biochem Soc Trans 1981;9:132-133
29. Kurosaki Y, Nishimura H, Terao K, et al. Existence of a specialized absorption mechanism for cefadroxil, an aminocephalosporin antibiotic, in the human oral cavity. Int J Pharm 1992;82:165-169
30. Squier CA, Wertz PW. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ, editor, Oral mucosal drug delivery, Marcel Dekker, Inc., New York; 1996. p. 1-26
31. Squier CA. The permeability of keratinized and non keratinized oral epithelium to horseradish peroxidase. J Ultrastruct Res 1973;43:160-177
32. Squier CA, Rooney L. The permeability of keratinized and non keratinized oral epithelium to lanthanum in vivo. J Ultrastruct Res 1976;54:286-295
33. Hill MW, Squier CA. The permeability of oral palatal mucosa maintained in organ culture. J Anat 1979;128:169-178
34. Dowty ME, Knuth KE, Irons BK, Robinson JR. Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro. Pharm Res 1992;9:1113-1122
35. Squier CA, Lesch CA. Penetration pathways of different compounds through epidermis and oral epithelia. J Oral Pathol 1988;17:512-516
36. Squier CA. Effect of enzyme digestion on the permeability barrier in keratinizing and non keratinizing epithelia. Br J Dermatol 1984;111:253-264
37. Dowty ME, Knuth KE, Robinson JR. Enzyme characterisation studies on the rate limiting barrier in rabbit buccal mucosa. Int J Pharm 1992;88:293-302
38. Chattarajee SC, Walker RB. Penetration enhancer classification. In: Smith EW, Maibach HI, editors, Percutaneous penetration enhancement, CRC Press, Boca Raton, FL; 1995. p. 1-4
39. Aungst A. Permeability and metabolism as barriers to transmucosal delivery of peptides and proteins. In: Hsieh DS, editor, Drug permeation enhancement. Theory and applications, New York: Marcel Dekker, 1994. p. 323-343
40. Lee VHL, Yamamoto A. Penetration and enzymatic barriers to peptide and protein absorption. Adv Drug Deliv Rev 1990;4:171-207
41. Hayashi M, Hirasawa T, Muraoka T, et al. Comparison of water influx and sieving coefficient in rat jejunal, rectal and nasal absorption of antipyrine. Chem Pharm Bull 1985;33:2149-2152
42. Kamda A, Nishihata T, Kim S, et al. Study of enamine derivatives of phenyl glycine as adjuvant for the rectal absorption of insulin. Chem Pharm Bull 1981;29:2012-2019
43. Barry BW. Dermatological formulations, percutaneous absorption. In: Barry BW, editor. New York: Marcel Dekker, 270 Madison Avenue10016; 1983. p. 127-233
44. Junginger HE, Verhoef JC. Macromolecules as safe penetration enhancers for hydrophilic drugs -a fiction? Pharm Sci Tech Today 1998;1:370-376
45. Lee VHL. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J Control Release 1990;3:213-223
46. Nicolazzo JA, Reed BL, Finnin B. Buccal penetration enhancers: how do they really work? J Control Release 2005;105:1-15
47. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603-618
48. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery - A promising option for orally less efficient drug. J Control Release 2006;114:15-40
49. Okada H, Yashiki T, Mima H. Vaginal absorption of a potent luteinizing hormone releasing hormone analogue (leuprolide) in rats III: effects of estrous cycle on vaginal absorption of hydrophilic model compounds. J Pharm Sci 1983;72:173-176
50. Nishihata T, Kim S, Morishita S, et al. Adjuvant effects of glyceryl esters of acetoacetic acid on rectal absorption of insulin and inulin in rabbits. J Pharm Sci 1983;72:280-285
51. Nishihata T, Okamura Y, Kamada A, et al. Enhanced bioavailability of insulin after rectal administration with enamine as adjuvant in depancreatized dogs. J Pharm Pharmacol 1985;37:22-26
52. Windsor E, Cronheim GE. Gastro-intestinal absorption of heparin and synthetic heparinoids,. Nature 1961;190:263-264
53. Yamashita S, Saitoh H, Nakanishi K, et al. Characterization of enhanced intestinal permeability; electrophysiological study on the effects of diclofenac and ethylenediamine tetraacetic acid. J Pharm Pharmacol 1985;37:512-513
54. Sakai K, Kutsuna TM, Nishino T, et al. Contribution of calcium ion sequestration by polyoxyethylated nonionic surfactants to the enhanced colonic absorption of p-aminobenzoic acid. J Pharm Sci 1986;75:387-390
55. Martin GP, Marriott C, Kellaway IW. Direct effect of bile salts and phospholipids on the physical properties of mucus. Gut 1978;19:103-107
56. Madara JL, Dharmsathaphorn K. Occluding junction structure-function relationship in a cultured epithelial monolayer. J Cell Biol 1985;101:2124-2133
57. Ganem-Quintanar A, Kalia YN, Falson-Rieg F, Buri P. Mechanism of oral permeation enhancement. Int J Pharm 1997;156:127-142
58. Hao J, Heng PSW. Buccal delivery systems. Drug Dev Ind Pharm 2003;29:821-832
59. Sandri G, Rossi S, Bonferoni MC, et al. Buccal penetration enhancement properties of N-trimethyl chitosan: Influence of quaternization degree on absorption of a high molecular weight molecule. Int J Pharm 2005;297:146-155 (Pubitemid 40720274)
60. Sandri G, Rossi S, Ferrari F, et al. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur J Pharm Sci 2004;21:351-359
61. Bernkop-Schnurch A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm 2000;194:1-13
62. Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999;182:21-32
63. Hamman JH, Schultz CM, Kotze AF. Enhancement of paracellular drug transport across mucosal epithelia by N-trimethyl chitosan chloride. STP Pharm Sci 2000;10:35-38
64. Tengamnuay P, Sahamethapat A, Sailasuta A, Mitra K. Chitosan as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int J Pharm 2000;197:53-67
65. Senel S, Kremer MJ, Kas S, et al. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 2000;21:2067-2071
66. Sandri G, Poggi P, Bonferoni MC, et al. Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan. J Pharm Pharmacol 2006;58(10):1327-1336
67. Portero AC, Remunan-Lopez, Nielsen HM. The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model an in vitro model of the buccal epithelium. Pharm Res 2002;19:169-174
68. Siegel IA, Gordon HP. Effects of surfactants on the permeability of canine oral mucosa in-vitro. Toxicol Lett 1985;26:153-158
69. Murakami T, Yata N, Tamauchi Y, Kamada A. Studies of absorption promoters for rectal delivery preparations. II. A possible mechanism of promoting efficacy of enamine derivatives in rectal absorption. Chem Pharm Bull 1982;30:659-665
70. Murakami T, Sasaki Y, Yamajo R, Yata N. Effect of bile salts on the rectal absorption of sodium ampicillin in rats. Chem Pharm Bull 1984;32:1948-1955
71. Lee VHL. Enzymatic barriers to peptide and protein absorption and the use of penetration enhancers to modify absorption. In: Davis SS, Illum L, Tomlinson E, editors, Delivery systems for peptide drugs, Plenum Press, New York, NY; 1986. p. 87-104
72. Veuillez F, Kalia YN, Jacques Y, et al. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm 2001;51:93-109
73. Hogan DTO, Illum L. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine. Crit Rev Ther Drug Carrier Syst 1990;7:35-97
74. Yamamoto A, Luo AM, Dodda-Kashi S, Lee VHL. The ocular route for systemic insulin delivery in the albino rabbit. J Pharmacol Exp Ther 1989;249:249-255
75. Senel S, Capan Y, Sargon MF, et al. Histological and bioadhesion studies on buccal bioadhesive tablets containing a penetration enhancer sodium glycodeoxycholate. Int J Pharm 1998;170:239-245
76. Hoogstraate AJ, Wertz PHW, Squier CA, et al. Effects of the penetration enhancer glycodeoxycholate on the lipid integrity in porcine buccal epithelium in vitro. Eur J Pharm Sci 1997;5:189-198
77. Senel S, Capan Y, Sargon MF, et al. Enhancement of transbuccal permeation of morphine sulfate by sodium glycodeoxycholate in vitro. J Control Release 1997;45:153-162
78. Hoogstraate AJ, Verhoef JC, Tuk B, et al. Buccal delivery of fluorescein isothiocyanate-dextran 4400 and the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. J Control Release 1996;41:77-84 (Pubitemid 26246365)
79. Senel S, Hoogstraate AJ, Spies F, et al. Enhancement of in vitro permeability of porcine buccal mucosa by bile salts: kinetic and histological studies. J Control Release 1994;32:45-56
80. Hoogstraate AJ, Senel S, Cullander C, et al. Effects of bile salts on transport rates and routes of FTIC-labelled compounds across porcine buccal epithelium in vitro. J Control Release 1996;40:211-221
81. Wang Y, Zuo Z, Chow MSS. HO-1-u-1 model for screening sublingual drug delivery-Influence of pH, osmolarity, permeation enhancer. Int J Pharm 2009;370:68-74
82. Xiang J, Fang X, Li X. Transbuccal delivery of 2,3-ideoxy cytidine: in vitro permeation study and histological investigation. Int J Pharm 2002;231:57-66
83. Shin SC, Kim JY. Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur J Pharm Biopharm 2000;50:217-220
84. Dhiman MK, Dhiman A, Sawant KK. Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study. AAPS Pharm Sci Tech 2009;10(1):258-265
85. Yamamoto A, Hayakawa E, Lee VHL. Insulin and pro insulin proteolysis in mucosal homogenates of the albino rabbits: implications in peptide delivery from non oral routes. Life Sci 1990;47:2465-2474
86. Nakada Y, Awata C, Nakamichi C, Sugimoto I. The effect of additives on the oral mucosal absorption of human calcitonin in rats. J Pharmacobiol Dyn 1988;11:395-401
87. Artusi M, Santi P, Colombo P, Junginger HE. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. Int J Pharm 2003;250:203-213
88. Colonna C, Genta I, Perugini P, et al. 5-Methyl-Pyrrolidinone Chitosan Films as Carriers for Buccal Administration of Proteins. AAPS Pharm Sci Tech 2006;7:E1-E7
89. Sandri G, Bonferoni MC, Rossi S, et al. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Eur J Pharm Biopharm 2007;65(1):68-77
90. Sahni JK, Chopra S, Ahmad FJ, Khar RK. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications. J Pharm Pharmacol 2008;60(9):1111-1119
91. Sadeghi AM, Dorkoosh FA, Avadi MR, et al. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharm Biopharm 2008;70(1):270-278
92. Ahad A, Aqil M, Kohli K, et al. Chemical penetration enhancers: a patent review. Expert Opin. Ther. Patents 2009;19(7):969-988
93. Silvestre AJD, Gandini A. Terpenes: major sources, properties and applications monomers, polymers and composites from renewable resources. Elsevier: Amsterdam, Boston; 2008. p. 17-38
94. Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today 2007;12:1061-1067
95. Shojaei AH, Khan M, Lim G, Khosravan R. Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer. Int J Pharm 1999;192:139-146
96. Ceschel GC, Maffei P, Moretti MDL, et al. In vitro permeation through porcine buccal mucosa of Salvia desoleana Atzei & Picci essential oil from topical formulations. Int J Pharm 2000;195:171-177
97. Coutel-Egros A, Maitani Y, Veillard M, et al. Combined effects of pH, co-solvent and penetration enhancers on the in vitro buccal absorption of propranolol through excised hamster cheek pouch. Int J Pharm 1992;84:117-128
98. Kitano M, Maitani Y, Takayama K, Nagai T. Buccal absorption through golden hamster cheek pouch in vitro and in vivo of 17beta-estradiol from hydrogels containing three types of absorption enhancers. Int J Pharm 1998;174:19-28
99. Attia MA, EI-Gibaly I, Shaltout SE, Fetih GN. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int J Pharm 2004;276:11-28
100. Siegel IA, Gordon HP. Surfactant-induced alterations of permeability of rat oral mucosa to non-electrolytes in-vivo. Arch Oral Biol 1985;30:43-47
101. Steward A, Bayley DL, Howes C. The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interferon. Int J Pharm 1994;104:145-149
102. Aungst BJ, Rogers NJ. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int J Pharm 1989;53:227-235
103. Shin SC, Bum JP, Choi JS. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int J Pharm 2000;209:37-43
104. Gandhi R, Robinson J. Mechanisms of penetration enhancement for transbuccal delivery of salicylic acid. Int J Pharm 1992;85:129-140
105. Figueiras A, Hombach J, Veiga F, Bernkop-Schnurch A. In vitro enhancing effect of 1-dodecylazacycloheptan-2-evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery. Eur J Pharm Biopharm 2009;71:339-345
106. Marttin E, Verhoef JC, Cullander C, et al. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers. Pharm Res 1997;14:631-637
107. Hovgaard L, Bronsted H. Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins. Pharm Res 1995;12:1328-1332
108. Marttin E, Verhoef JC, Spies F, et al. The effect of methylated betacyclo- dextrins on the tight junctions of the rat nasal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visualization studies. J Control Release 1999;57:205-213
109. Stoughton RB. Enhanced percutaneous penetration with dodecylaza- cycloheptan- 2-one. Arch Dermatol 1982;118:474-477
110. Stoughton RB, McClure WO. Azone®, a new non-toxic enhancer of percutaneous penetration. Drug Dev Ind Pharm 1983;9:725-744
111. Kurosaki Y, Hisaichi S, Nakayama T, et al. Enhancing effect of 1-dodecylaza-cycloheptan-2-one (Azone®) on the absorption of salicylic acid from keratinized oral rnucosa and the duration of enhancement in vivo. Int J Pharm 1989;51:47-54
112. Nicolazzo JA, Reed BL, Finnin BC. Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Control Release 2005;105:240-248
113. Barry BW. Mode of action of penetration enhancers in human skin. J Control Release 1987;6:85-97
114. Hadgraft J, Williams DG, Allan G. Azone® mechanisms of action and clinical effect. In: Walters KA, Hadgraft J, editors, Pharmaceutical skin penetration enhancement, New York: Marcel Dekker; 1993. p. 175-197
115. Tsutsumi K, Obata Y, Takayama K, et al. Effect of the cod-liver oil extract on the buccal permeation of ionized and non ionized forms of ergotamine using the keratinized epithelial-free membrane of hamster cheek pouch mucosa. Int J Pharm 1998;174:151-156
116. Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointment. J Soc Cosmet Chem 1960;11:85-97
117. Loftsson J, Gudmundsdottir TK, Fridriksdottir H, et al. Fatty acids from cod-liver oil as skin penetration enhancers. Pharmazie 1995;50:188-190
118. Starokadomskyy PL, Dubey IY. Lysalbinic acid - a new absorption enhancer for the buccal delivery of peptide drugs. Kyiv Ukraine 2005;6:79-85
119. Starokadomskyy PL, Dubey IY. New absorption promoter for the buccal delivery: Preparation and characterization of lysalbinic acid. Int J Pharm 2006;308:149-154
120. Starokadomskyy PL. New possibilities of chewing gum in local therapy. In: Proceedings of the Conference for Young Scientists, PhD Students and Students, Institute of Molecular Biology and Genetics, Kyiv, Ukraine, September 25-27; 2003. p. 263
121. Soyani AP, Chien YW. Systemic delivery of peptides and proteins across absorptive mucosae. Crit Rev Ther Drug Carrier Syst 1996;13:85-184
122. Remon JP. Absorption enhancers. In: Swarbrick J, editor, Encyclopedia of pharmaceutical technology. 3rd edition. Informa Healthcare: London, UK; 2006; Vol-1. p. 13-15